EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
1-Year Est. Return 7.54%
This Quarter Est. Return
1 Year Est. Return
+7.54%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.68B
AUM Growth
-$820M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
61
New
Increased
Reduced
Closed

Top Buys

1
+$33.3M
2
+$26.6M
3
+$17.8M
4
BEAM icon
Beam Therapeutics
BEAM
+$10.3M
5
QURE icon
uniQure
QURE
+$6.24M

Top Sells

1
+$129M
2
+$56.4M
3
+$32.7M
4
NMRA icon
Neumora Therapeutics
NMRA
+$22M
5
CRGX
CARGO Therapeutics
CRGX
+$21.2M

Sector Composition

1 Healthcare 99.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBIO icon
51
Generation Bio
GBIO
$35.4M
– –
-204,687
GLUE icon
52
Monte Rosa Therapeutics
GLUE
$741M
– –
0
HOOK
53
DELISTED
HOOKIPA Pharma
HOOK
– –
-388,861
KYMR icon
54
Kymera Therapeutics
KYMR
$4.31B
– –
-350,000
MLTX icon
55
MoonLake Immunotherapeutics
MLTX
$643M
– –
-332,522
MRSN icon
56
Mersana Therapeutics
MRSN
$40.7M
– –
-453,120
NMRA icon
57
Neumora Therapeutics
NMRA
$452M
– –
-2,071,450
PFE icon
58
Pfizer
PFE
$191B
– –
0
SWTX
59
DELISTED
SpringWorks Therapeutics
SWTX
– –
-1,560,000
THRD
60
DELISTED
Third Harmonic Bio
THRD
– –
-3,182,444
ARTV
61
Artiva Biotherapeutics
ARTV
$87.7M
– –
-41,453
1 2
3